USDA Issues Recall for Organic Ground Beef at Whole Foods Due to E. coli Contamination
The USDA has issued a recall for organic ground beef sold at Whole Foods due to possible E. coli contamination. Consumers are advised to discard affected products to prevent serious health risks.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) has issued a public health alert concerning certain packages of organic ground beef sold at Whole Foods stores nationwide. The affected product is labeled as "ORGANIC RANCHER ORGANIC GROUND BEEF 85% LEAN 15% FAT" and was produced on May 22 and 23, 2025. These packages display a "Use or Freeze By" date of June 19 or 20, 2025, and include the establishment number "EST. 4027" within the USDA inspection mark. Although this meat has been removed from store shelves, some packages may still be in consumers’ homes, posing a risk for consumption.
The FSIS urges customers who possess this product to discard it immediately or return it to the place of purchase. The recall covers ground beef distributed at Whole Foods locations across the United States and also sent to distributors in Connecticut, Georgia, Illinois, and Maryland. No cases of illness have been reported yet; however, E. coli bacteria, which can cause severe health issues, have been detected. E. coli infection symptoms include dehydration, abdominal cramps, and bloody diarrhea. The bacteria can lead to hemolytic uremic syndrome (HUS), a serious kidney condition that can cause easy bruising, pallor, and decreased urine output, especially among children under five years and older adults. Individuals experiencing these symptoms should seek emergency medical care.
Health officials emphasize caution, as E. coli is a potentially deadly pathogen. The incident highlights the importance of proper food handling and awareness of recalls to prevent illness from contaminated products. Further details and updates can be found in the full USDA health alert.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Integrating Machine Learning and Cell Imaging to Predict Multiple Sclerosis Treatment Outcomes
Researchers have developed a cutting-edge tool combining machine learning and high-content cell imaging to predict patient responses to natalizumab in multiple sclerosis treatment, promising more personalized and effective therapies.
Promising Oral Medication Improves Heart and Muscle Symptoms in Barth Syndrome
A new oral drug, MA-5, shows promising results in improving heart and muscle symptoms in Barth syndrome by targeting mitochondrial dysfunction. This breakthrough could lead to disease-modifying treatment options.
Revolutionizing Tissue Repair: Suture-Free Solutions for Better Healing
Innovative biopolymer technology from MIT enables surgeons to perform tissue repairs without sutures, promising less trauma and improved healing for patients.
Americans Favor Mitigating Lockdown Harms Over COVID-19 Mortality
A University of Michigan study reveals that most Americans prefer prioritizing the reduction of lockdown-related societal harms, such as child abuse and economic hardship, over preventing COVID-19 deaths, highlighting the importance of balanced public health policies.